To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis
Clinical trial NCT01533844 · TERMINATED
Trial details
- NCT number
- NCT01533844
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.